The "KRINGLE PHARMA" trademark, serial number 86028683 , was filed on 5th of August 2013 with a mark drawing code of 4000 and its transaction date is 86028683. The attorney assigned is Curtis B. Hamre, attorney docket number 20199.0024US. Since 24th of April 2014, the document can be found in the L10 law office in the publication and issue section. The date when we last checked the status of this trademark was 04/24/2014.

Prior registrations: 3266636

The corresponded responsible for this trademark is CURTIS B. HAMRE, located at HAMRE, SCHUMANN, MUELLER & LARSON, P.C., PO BOX 2902, MINNEAPOLIS, MN 55402.

The state or country where the trademark was organized is by Kringle Pharma, Inc.. The legal entity type behing it is a Corporation, located at 7-7-15, Saitoasagi, Ibaraki-shi, Osaka, zip .

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	6 - Active
Status Date	08/12/2013
Primary Code	005
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	08/12/2013
Primary Code	042
Goods codes
D10000	"PHARMA"
GS0051	Pharmaceutical, veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; Sanitary preparations for medical use; Central nervous system stimulants; Hair growth stimulant; Antipyretic analgesics; Anti-epileptics; Analeptics; Hypnotic sedatives; General anesthetics; Anti-motion sickness preparations; Pharmaceutical preparations acting on the peripheral nervous system; Local anesthetics; Skeletal muscle relaxants; Anhidrotics; Autonomics; Antispasmodics; Diaphoretics; Pharmaceutical preparations acting on the sensory organs; Ophthalmic preparations; Agents for otic and nasal use, namely, nasal spray preparations, eye washes, eye drops, irrigating solutions for eye use; Treatment for eye infection, macular degeneration, retinopathy, rhinitis, and sinusitis; Pharmaceutical antiallergic preparations; Antihistaminics; Cardiovascular treatment preparations; Cardiotonics; Antihypertensives; Vasoconstrictors; Capillary stabilizers; Cerebral hemorrhage prophylactic preparations; Antiarrhythmic preparations; Diuretics; Pharmaceutical preparations acting on respiratory organs; Respiratory stimulants; Anti-cough drops; Antitussive expectorants; Pharmaceutical preparations acting on digestive organs; Gastrointestinal cleaning agents; Clysters; Evacuants (purgatives); Stomachics and digestives; Pharmaceutical preparations for oral use, and for oral inflammation; Emetics; Pharmaceutical preparations for dental purposes for gingivostomatitis, alveolar abscess, and alveoloclasia; Antacids; Antiemetics; Castor oil for medical purposes; Cholagogues; Hormones for medical purposes; Thyroid and para-thyroid hormone preparations; Mixed hormone preparations; Estrogen preparations; Pancreas hormone preparations; Salivary gland hormone preparations; Androgen preparations; Pituitary hormone preparations; Adrenal hormone preparations; Pharmaceutical preparations acting on uro-genital and anal organs; Oxytocics; Anti-hemorrhoidals; Emmenagogues; Contraceptives; Medicated skin care preparations; Pharmaceutical preparations for purulence; Anti-dermoinfectives; Antimicrobials for dermatologic use; Astringents; Anti-inflammatory agents; Analgesics; Anti-itchings; Talcum powder for medical purposes; Medicated baby oils; Medicated baby powders; Medicated bath preparations; Vitamin preparations for medical purposes; Cod-liver oil drops for medical purposes; Mixed vitamin preparations for medical purposes; Vitamin A preparations for medical purposes; Vitamin C preparations for medical purposes; Vitamin D preparations for medical purposes; Vitamin B preparations for medical purposes; Multi-vitamin preparations for medical purposes; Amino acid preparations for medical purposes; Threonine preparations; Tryptophane preparations; Methionine preparations; Lysine preparations; Royal jelly for medical purposes; Calcium supplements for medical purposes; Chondroitin preparations for medical purposes; Protein and amino acid preparations for medical purposes; Saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; Mineral preparations for medical use; Anticoagulants; Blood substitutes for human and veterinary use; Blood plasma; Hemostatics; Pharmaceutical preparations affecting metabolism; Antidotes; Enzyme preparations for medical purposes; Lactagogues; Lipotropic factor preparations; Pharmaceutical preparations for the treatment of habitual intoxication; Pharmaceutical preparations for activating cellular function; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical preparations for treating physically caused lesions; Pharmaceutical preparations for treating heatstroke; Radiation sickness treating drugs; Pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn, side effect of anticancer drugs, and immunosuppresants; Chlorine-detoxication preparations; Arsenic-detoxication preparations; Benzol-detoxication preparations; Antibiotic preparations; Erythromycin preparations; Chloramphenicol preparations; Colistin-polymixin preparations; Sarkomycin preparations; Streptomycin preparations; Thiolutin preparations; Tetracycline preparations; Trichomycin preparations; Mixed antibiotic preparations; Penicillin preparations; Chemotherapeutics; Antisyphilitics; Antituberculous preparations; Sulfonamide preparations; Antileprotic preparations; Biological preparations for medical purposes; Antitoxic sera; Antitoxins; Mixed biological preparations for medical purposes; Preparations for biological tests for medical purposes; Toxoids; Vaccines; Preparations for destroying parasites; Anthelmintics; Odor neutralizing preparations for use on drugs; Pharmaceutical excipients; Diagnostic preparations for medical use; X-ray contrast agents; Diagnostic reagents for medical use; Diagnostic media for bacteriological cultures for medical use; Radio isotope markers for therapeutic or diagnostic use; Opium alkaloid preparations; Synthetic narcotics; Coca alkaloid preparations; Mosquito-repellent incenses; Germicides and fungicides; Rodenticides; Insecticides; Fumigants; Herbicides, namely, weedkillers; Insect-repellents; Antiseptics
GS0421	Testing, inspection or research of pharmaceuticals and genetics; Medical research; Consultancy and providing information services in the field of testing, inspection or research of pharmaceuticals and genetics; Consultancy and providing information services in the field of medical research; Providing medical and scientific research information and advice in the fields of pharmaceuticals and genetics
PM0000	KRINGLE PHARMACEUTICAL

FOREGIN REGISTRATION
Foreign Filing Date	08/01/2013
Foreign Registration Date	12/06/2013
Foreign Expiration Date	12/06/2023
Foreign Application Number	T2013-059887
Country	JP
Foreign Registration Number	5635554

PROSECUTION HISTORY
Date	Description	Type	Code
04/24/2014	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
04/24/2014	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
04/14/2014	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
04/01/2014	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2013	NOTIFICATION OF NON-FINAL ACTION E-MAILED	O - Outgoing Correspondence	GNRN
11/21/2013	NON-FINAL ACTION E-MAILED	F - First Action	GNRT - NON-FINAL ACTION E-MAILED
11/21/2013	NON-FINAL ACTION WRITTEN	R - Renewal	CNRT - NON-FINAL ACTION WRITTEN
11/19/2013	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
08/13/2013	NOTICE OF PSEUDO MARK E-MAILED	E	MPMK
08/12/2013	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
08/08/2013	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.